0001950047-23-005553.txt : 20231201 0001950047-23-005553.hdr.sgml : 20231201 20231201161929 ACCESSION NUMBER: 0001950047-23-005553 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 231459790 BUSINESS ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-580-3099 MAIL ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MIGAUSKY GEORGE V CENTRAL INDEX KEY: 0001134365 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O DYAX CORP. STREET 2: 300 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001134365 XXXXXXXX LIVE 0001764013 IMMUNOVANT INC 001-38906 320 WEST 37TH STREET New York NY 10018 917-580-3099 GEORGE V MIGAUSKY Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

12700 496951.00 144661930 12/01/2023 NASDAQ Common 05/15/2022 Restricted Stock Units Issuer N 12700 05/15/2022 N/A Y The securities to be sold were acquired upon the vesting of restricted stock units during the period of 5/15/2021 through 5/15/2022 12/01/2023 05/24/2023 /s/ George V Migausky